Home Combat Arthritis Roche's Rheumatoid Arthritis Drug Actemra Fails to Help COVID-19 Patients With Pneumonia

Roche's Rheumatoid Arthritis Drug Actemra Fails to Help COVID-19 Patients With Pneumonia

Jun 26, 2020 comments off

Roche’s Rheumatoid Arthritis Drug Actemra Fails to Help COVID-19 Patients With Pneumonia

There are still two ongoing studies of the drug in patients infected with the novel coronavirus.

Read More…

You May Also Like

U.S. FDA seeks new warnings on drugs from Pfizer, Lilly and AbbVie – Reuters

Antibody levels higher after Moderna shot; Lilly arthritis drug used with steroid cuts death risk – Reuters

WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients – Reuters India

Podiatrists debunk 12 feet myths

NIH starts study of COVID-19 booster shot in people with autoimmune diseases – Reuters

Pharma Stock Roundup: PFE's COVID Jab Full Approval by FDA, JNJ's Booster Data